Medical Research
At CAF, Medical Research is Key
Medical researchers who are interested in initiating a thalassemia-related project or who have an existing project that requires additional funding: The Cooley’s Anemia Foundation may be just what you need.
CAF has a decades-long history of supporting innovative and important research in thalassemia. Our established and respected Medical Fellowship program has funded numerous early career individuals who have continued to stay in the thalassemia field and make important contributions to the scientific and clinical study of thalassemia.
Our Support for Ongoing Clinical Research in Thalassemia Grants and Clinical Trials in Thalassemia Cell and Gene Therapy Grants are aggressively pushing forward the understanding of issues of concern to the growing thalassemia population and helping to propel advances in areas of primary importance.
Wednesday, October 9th, 2024
The Cooley’s Anemia Foundation is accepting applications for medical research grants and fellowships in areas related to thalassemia. The awards are in three categories: Clinical Trials in Thalassemia Cell & Gene Therapy Application Clinical Research Application Research Fellowship Application Details are as follows: Clinical Trials in Thalassemia Cell and Gene Therapy Application The Cooley’s Anemia […]
Read more
: Front Page, info foundation, info thalassemia, Links, medical professional, Medical Research, News
: CDC, clinical trials, Cooley's anemia, fellowship applications, gene therapy, grant application, grants and fellowships, medical research, medical research applications, rare disease, rare disease reasearch, registration, thalassemia, thalassemia medical research
Thursday, June 27th, 2024
We’re proud to announce five new Cooley’s Anemia Foundation Medical Research Fellowships for the 2024-2025 grant cycle. The total amount of funding for the research Fellowships is $250,000. These Fellowship recipients were assessed on the basis of the quality of the scientific content, the academic accomplishments and future promise of the investigator, the quality of […]
Read more
: Front Page, Grants & Fellowships, medical professional, Medical Research, News
: Cooley's anemia, fellowships, grants, medical research, medical research for thalassemia, pharma, Thalassaemia International Federation, thalassemia, thalassemia awareness, thalassemia care, TIF
Thursday, June 20th, 2024
*IMPORTANT: The following information is a press release that has been released in advance of the date being presented for peer review* Agios Pharmaceuticals announced Monday that its drug Pyrukynd (mitapivat), an oral pyruvate kinase activator, reached its primary endpoint in a Phase III trial evaluating adults with the blood disorder transfusion-dependent alpha- or beta-thalassemia. […]
Read more
: Blog, Front Page, info thalassemia, Medical Research, News
: Agios, blood disorder, blood transfusion, Cooley's anemia, pharma, Thal Pals, Thalassaemia International Federation, thalassemia, thalassemia awareness, TIF
Tuesday, February 6th, 2024
Care Walk is the Cooley’s Anemia Foundation’s annual fundraising event and opportunity to bring together the thalassemia community and its supporters around the country. Funds raised support medical research to fight thalassemia, a genetic blood disorder, as well as patient support services for thalassemia patients across the country. Click here to register for Care Walk!! […]
Read more
: Blog, Care Walk, Events, Front Page, info foundation, info thalassemia, Links, Medical Research, News, person with thalassemia, Upcoming Events
: beta-thalassemia, Care Walk, care walk 2024, Care Walk Spotlight, CDC, Cooley's anemia, fundraiser, medical research, pharma, registration, Thal Pals, thalassemia, thalassemia awareness, thalassemia care, thalassemia care walk, thalassemia cure, thalassemia fundraiser, thalassemia medical research, what is thalassemia
Wednesday, January 17th, 2024
The FDA has approved Vertex and CRISPR’s gene-editing therapy Casgevy to treat beta thalassemia. Casgevy becomes the first therapy for the rare blood disorder to use the innovative CRISPR gene-editing technology. Vertex Pharmaceuticals and CRISPR Therapeutics have scored an FDA approval for their gene-editing therapy Casgevy (exa-cel) to treat transfusion-dependent beta thalassemia (TDT). The approval […]
Read more
: Blog, Front Page, info thalassemia, Links, Medical Research, News, person with thalassemia
: beta thalassemia cure, beta-thalassemia, casgevy, Cooley's anemia, CRISPR, gene editing, gene therapy, medical research, pharma, thalassemia, thalassemia cure, thalassemia treatment, vertex
Wednesday, January 3rd, 2024
Agios Announces Phase 3 ENERGIZE Study of Mitapivat Met Primary Endpoint and Both Key Secondary Endpoints in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia January 3, 2024 – Agios Pharmaceuticals, Inc. today announced that the global Phase 3 ENERGIZE study of mitapivat in adults with non-transfusion-dependent (NTD) alpha- or beta-thalassemia achieved its primary endpoint of […]
Read more
: Blog, Front Page, info thalassemia, medical professional, Medical Research, News, person with thalassemia, Webinars
: Agios, agospharmaceuticals, alpha thalassemia, beta-thalassemia, cooleys anemia foundation, energize, i have thalassemia, medical research for thalassemia, pharma, thalassemia, thalassemia care, thalassemia treatment, what is thalassemia
Tuesday, September 19th, 2023
Care Walk is the Cooley’s Anemia Foundation’s annual fundraising event and opportunity to bring together the thalassemia community and its supporters around the country. Funds raised support medical research to fight thalassemia, a genetic blood disorder, as well as patient support services for thalassemia patients across the country. Your Walk, Your Way! Care Walk is set up […]
Read more
: Care Walk, Chicago Chapter, Donors, Front Page, have thalassemia trait, info foundation, info thalassemia, Links, Medical Research, News, person with thalassemia, Upcoming Events
: about thalassemia, Care Walk, care walk 2023, Cooley's anemia, thalassemia, thalassemia awareness, thalassemia care, thalassemia cure, thalassemia fundraising, thalassemia major, what is thalassemia
Wednesday, August 30th, 2023
The Cooley’s Anemia Foundation is accepting applications for medical research grants and fellowships in areas related to thalassemia. The awards are in three categories: Clinical Trials in Thalassemia Cell & Gene Therapy Clinical Research Application Research Fellowship Application Details are as follows: CLINICAL TRIALS IN THALASSEMIA CELL AND GENE THERAPY The Cooley’s Anemia Foundation invites […]
Read more
: Front Page, Grants & Fellowships, info thalassemia, Medical Research, News, person with thalassemia
: clinical research, clinical trials, fellowships, gene therapy, grants, medicial research, thalassemia, thalassemia research
Tuesday, June 20th, 2023
We’re proud to announce two new Cooley’s Anemia Foundation Medical Research Fellowships and two renewal Medical Research Fellowships for the 2023-2024 grant cycle. The total amount of funding for the two research Fellowships is $200,000. These Fellowship recipients were assessed on the basis of the quality of the scientific content, the academic accomplishments and future […]
Read more
: Grants & Fellowships, medical professional, Medical Research
: doctors, fellowships, grants, medical, medical research, patients, research, thalassemia
Friday, November 4th, 2022
The Cooley’s Anemia Foundation is accepting applications for medical research grants and fellowships in areas related to thalassemia.
Read more
: Front Page, Grants & Fellowships, Medical Research, News
: application, Clinical Trials in Thalassemia Cell and Gene Therapy, fellowships, gene therapy, grant, grants, medical research, Ongoing Clinical Research in Thalassemia, Research Fellowships